Towards an HIV Cure; clinical strategies and trials | Jintanat Ananworanich, MD, PhD
Lecture: Towards an HIV Cure; clinical strategies and trials
Speaker: Jintanat Ananworanich, MD, PhD
US Military, HIV Research Program MHRP, United States of America
Presented at: Asia Pacific AIDS & Co-Infections Conference (APACC) 2016 | The Opening Session
For more medical education programs, as well as the latest scientific information, visit https://academicmedicaleducation.com/
Register for our platform: https://academicmedicaleducation.com/user/register
Sign up for our newsletter: https://amededu.activehosted.com/f/13
Upcoming meetings: https://academicmedicaleducation.com/programs
APACC provides a much-needed scientific platform that focuses on the developments, issues, and needs in the Asia Pacific region. Researchers have the opportunity to present and discuss the latest developments and are offered opportunities for interaction, networking, and building collaborations. Top experts integrate science and clinical practice through state-of-the-art lectures, clinical case discussions, round table discussions, and debates in order to reach consensus on best practices and inform how treatment guidelines are implemented.
For the Enduring Materials of the 2016 edition of APACC visit https://bit.ly/3ykvMgy
Видео Towards an HIV Cure; clinical strategies and trials | Jintanat Ananworanich, MD, PhD канала Academic Medical Education
Speaker: Jintanat Ananworanich, MD, PhD
US Military, HIV Research Program MHRP, United States of America
Presented at: Asia Pacific AIDS & Co-Infections Conference (APACC) 2016 | The Opening Session
For more medical education programs, as well as the latest scientific information, visit https://academicmedicaleducation.com/
Register for our platform: https://academicmedicaleducation.com/user/register
Sign up for our newsletter: https://amededu.activehosted.com/f/13
Upcoming meetings: https://academicmedicaleducation.com/programs
APACC provides a much-needed scientific platform that focuses on the developments, issues, and needs in the Asia Pacific region. Researchers have the opportunity to present and discuss the latest developments and are offered opportunities for interaction, networking, and building collaborations. Top experts integrate science and clinical practice through state-of-the-art lectures, clinical case discussions, round table discussions, and debates in order to reach consensus on best practices and inform how treatment guidelines are implemented.
For the Enduring Materials of the 2016 edition of APACC visit https://bit.ly/3ykvMgy
Видео Towards an HIV Cure; clinical strategies and trials | Jintanat Ananworanich, MD, PhD канала Academic Medical Education
Показать
Комментарии отсутствуют
Информация о видео
6 апреля 2021 г. 19:20:54
00:23:09
Другие видео канала
HIV Therapy in Development at American Gene Technologies - A Non-Technical OverviewHIV vaccines and broadly neutralizing monoclonal antibody - role in the cure ... | Sandhya Vasan, MDVirtual Press Conference: FDA Clears AGT to Begin Phase 1 Clinical Trial of HIV Cure ProgramAdult ADHD - what is it, and how can it be treated? - Harley TherapyVE-Panel 2B: Future design approaches for HIV vaccine efficacy trialsCriselda Kananda's journey as an aids activistHIV and AIDS Explained in a Simple Way in Hindi | HIV Mechanism of Action | Mini Jankaari SeriesVisualizing HIV Infection: Seeking Clues Towards an HIV-1 Vaccine and CureFunctional Cure of HIV-1 Infection by PD1-vaccine-based Immunotherapy | Zhiwei Chen, PhD, DVMWhat’s new in Hepatitis B treatment & diagnostics | Seng Gee Lim, MBBS, FRACP, FRCP, MDPerspectives on the Pandemic | "Blood Clots and Beyond" | Episode 15amfAR: 1985-2021 and BeyondHBV therapy & Approaches to Cure | Jordan Feld, MD, MPHFrom mRNA Science to Virus Vectors: It's Prime Time for Vaccine Technology | NBC News‘भारत को साल 2030 तक बनाया जाएगा AIDS FREE' !E-meeting: Developments in the HIV prevention pipeline: PrEP, vaccines and moreHIV Vaccine Pipeline and Progress, Including Broadly Neutralizing Antibodies - Glenda GrayHow ADHD Treatment Is Not ADHD FriendlyHIV Vaccine Quest – Where do we Stand? | Carte Blanche | M-NetDual Regimen – What Are the Resistance Considerations - Ricardo Diaz, MD